Lessons Learnt From Glioblastoma Surviving 20 Years Progression Free: A Case Report
1Department of Neurosurgery, HMC Hospital and Advanced Neuro Spine Institute, Ludhiana, Punjab, India.
Neurology India
|May 23, 2025
Summary
This case study highlights a glioblastoma patient who survived over 20 years after gross total removal and irradiation. It suggests achieving complete tumor resection may offer long-term survival for some glioblastoma patients.
Area of Science:
- Neuro-oncology
- Neurosurgery
Background:
- Glioblastoma (GBM) is an aggressive primary brain tumor with a typically poor prognosis, often leading to short survival times.
- Current treatment strategies often prioritize subtotal resection for functional preservation, which may not be optimal for patient outcomes.
Observation:
- A 22-year-old male presented with symptoms of increased intracranial pressure and focal neurological deficits.
- The patient underwent gross total removal (GTR) of the glioblastoma.
- Following GTR and adjuvant irradiation, the patient has remained recurrence-free for over 20 years.
Findings:
- This case demonstrates a rare instance of long-term survival exceeding 20 years in a glioblastoma patient.
- Achieving gross total resection, in conjunction with radiotherapy, may be associated with prolonged survival in select glioblastoma cases.
Implications:
- This case offers hope for extended survival in glioblastoma patients and supports the pursuit of GTR when feasible.
- Preserving tissue specimens for future molecular testing and fostering strong patient-physician relationships for long-term follow-up are crucial.
Related Concept Videos
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K


